BioSpace News Archive

Press Releases

Actinogen confirms 100th participant in XanaMIA phase 2b/3 Alzheimer’s disease trial and interim analysis timeline

June 30, 2025
·
8 min read
Press Releases

AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR BEMARITUZUMAB IN FIBROBLAST GROWTH FACTOR RECEPTOR 2b (FGFR2b) POSITIVE FIRST-LINE GASTRIC CANCER

June 30, 2025
·
11 min read
Press Releases

AbbVie to Acquire Capstan Therapeutics, Further Strengthening Commitment to Transforming Patient Care in Immunology

June 30, 2025
·
6 min read
Press Releases

Autonomix Medical, Inc. Treats First Patient in Follow-On Market Expansion Phase (“PoC 2”) of Proof-of-Concept Human Clinical Study

June 30, 2025
·
4 min read
Press Releases

Allarity Therapeutics Receives Australian Patent Acceptance Notice for Stenoparib DRP® Companion Diagnostic

June 30, 2025
·
5 min read
Press Releases

Bausch + Lomb Will Release Second-Quarter 2025 Financial Results on July 30 and Hold Investor Day on Nov. 13

June 30, 2025
·
1 min read
Press Releases

Kyverna Therapeutics Announces Appointment of New Chief Financial Officer

June 30, 2025
·
6 min read
Press Releases

Novocure to Report Second Quarter 2025 Financial Results

June 30, 2025
·
3 min read
Press Releases

Plus Therapeutics Announces FDA Agreement to Initiate ReSPECT-LM Dose Optimization Trial for REYOBIQ™ in Leptomeningeal Metastases

June 30, 2025
·
9 min read
Press Releases

23andMe Receives Court Approval for Sale to TTAM Research Institute, a Nonprofit Public Benefit Corporation

June 30, 2025
·
6 min read